Diego Dal Ben
Via Madonna Delle Carceri, S.n.c
Camerino, 62032, Italy
Camerino, 62032, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
A Holistic Approach to Identifying a Positron Emission Tomography (PET) Tracer Candidate for In Vivo Imaging of Purinergic P2X7 Receptor in Neuroinflammation.
Journal: ACS pharmacology & translational science
Published: December 23, 2025
A2A Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson's Disease.
Journal: Cells
Published: December 30, 2024
A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: December 28, 2024
Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer.
Journal: Biomolecules
Published: August 28, 2024
Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A2A Adenosine Receptor Useful in Neurodegenerative Disorders.
Journal: Molecules (Basel, Switzerland)
Published: May 10, 2023
"Dual Anta-Inhibitors" of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 21, 2022
Machine Learning Scoring Functions for Drug Discovery from Experimental and Computer-Generated Protein-Ligand Structures: Towards Per-Target Scoring Functions.
Journal: Molecules (Basel, Switzerland)
Published: December 07, 2022
A patent review of adenosine A2B receptor antagonists (2016-present).
Journal: Expert opinion on therapeutic patents
Published: April 07, 2022
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
Journal: Molecules (Basel, Switzerland)
Published: March 09, 2022
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 01, 2022
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 30, 2021
Last Updated: 09/26/2026